Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.

Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.

The present invention provides novel and improved stimulus responsive polymers and methods of using the same for the purification of biomolecules.

The present invention provides novel and improved stimulus responsive polymers and methods of using the same for the purification of biomolecules.

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO.sub.3.sup.− or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO.sub.3.sup.− or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

The subject of the invention is an N-sulfonic polyallylamine derivative (NSPAH) with Formula 1, wherein R is —SO.sub.3.sup.− or —H, and n is an integer from 150 to 15000; an application of the N-sulfonic polyallylamine derivative as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus; as well as a pharmaceutical composition comprising the N-sulfonic polyallylamine derivative and application thereof.

Disclosed are hydrophobic, acrylic materials having both high refractive index and a high Abbe number. The materials may have an internal wetting agent, are well suited for use as implantable ophthalmic devices, and have a refractive index which may be edited through application of energy. When used for an intraocular lens, the high refractive index allows for a thin lens which compresses to allow a small incision size.

The present invention relates to an electrically conductive polymer composition having high dispersion stability in long-term storage without being influenced by air temperature changes in the winter season, the summer period, etc. and a method for stably storing an electrically conductive polymer solution. An electrically conductive polymer composition comprising at least a N-vinyl carboxylic acid amide polymer having a weight-average molecular weight within the range of not less than 5000 and not more than one million, an electrically conductive polymer, and a solvent. A method for stably storing an electrically conductive polymer solution, the method comprising adding, to an electrically conductive polymer solution, a N-vinyl carboxylic acid amide polymer having a weight-average molecular weight within the range of not less than 5000 and not more than one million.

The present invention relates to an anti-tack formulation of high solids content that uses effective amounts of a fine particle size talc, a water soluble cationic polymer, one or more nonionic surfactants, and one or more alkali metal fatty acid soaps. The high solids content anti-tack formulation is capable of being easily shipped to a customer's location and is stable and easily pumped after shipment to a customer. The high solids content anti-tack formulation generates a micro-flocculated pigment dispersion that can be subsequently diluted to a low solids content formulation for use in anti-tack applications, particularly rubber slab dipping applications. The anti-tack formulation provides improved anti-tack performance when coating uncured rubber products.